Sign in

CIK 0001357459

  • Non-accelerated filer
  • Smaller reporting company

PALISADE BIO, INC.

Sign in to watch
Ticker
PALI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
522007292
Phone
+1 858-704-4900
Business address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
Former names
PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
Open-market buys, last 90 days
$28,800
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Williams Donald Allen +$29K Director 1 filing

Reading 87 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-06 Finley John David CEO CFO Exercise or conversion +3,227,384 3,356,672
2026-10-06 Finley John David CEO CFO Shares withheld for taxes −1,411,982 $1.49 $2.1M 1,944,690
2026-10-06 Finley John David CEO CFO Exercise or conversion · Restricted Stock Units −3,059,800 6,119,600
2026-10-06 Finley John David CEO CFO Exercise or conversion · Restricted Stock Units −167,584 1,508,249
2026-08-19 Finley John David CEO, CFO Gift −88,400 129,288
2026-08-19 Finley John David CEO, CFO Gift +88,400 88,451
2026-07-07 Finley John David CEO, CFO Sale −146,798 $2.07 $303K 217,555
2026-07-07 Finley John David CEO, CFO Exercise or conversion +133 $0.70 $93 217,688
2026-07-07 Finley John David CEO, CFO Exercise or conversion · Series 2 Common Stock Purchase Warrant −133 0
2026-07-06 Finley John David CEO, CFO Exercise or conversion +335,167 364,353
2026-07-06 Finley John David CEO, CFO Exercise or conversion · Restricted Stock Units −335,167 1,675,833
2026-02-12 Finley John David CEO, CFO Sale −3,896 $1.75 $7K 27,353
2026-02-11 Finley John David CEO, CFO Exercise or conversion +13,333 31,249
2026-02-11 Finley John David CEO, CFO Exercise or conversion · Restricted Stock Units −13,333 26,667
2026-02-09 Finley John David CEO, CFO Grant or award · Restricted Stock Units +2,011,000 2,011,000
2025-10-06 Finley John David CEO, CFO Grant or award · Restricted Stock Units +9,179,400 9,179,400
2025-09-04 Finley John David CEO, CFO Grant or award · Phantom Units +323,400 323,400
2025-02-11 Finley John David CEO, CFO Grant or award · Stock Option (Right to Buy) +47,000 47,000
2025-02-11 Finley John David CEO, CFO Grant or award · Restricted Stock Units +40,000 40,000
2024-05-28 Finley John David CEO, CFO, Director Exercise or conversion +1,622 10,059

Page 1 of 6 · 112 trades